Company intelligence / Profile preview
Advanced Vision Research
- Ownership
- Private
- Development stage
- Other
Overview
Advanced Vision Research (AVR) was a pharmaceutical company dedicated to the development and marketing of products for ocular surface health, most notably the TheraTears brand. Founded by ophthalmologist Dr. Jeffrey Gilbard, the company specialized in treatments for dry eye syndrome and blepharitis using electrolyte-balanced formulas designed to replicate natural tears. Its commercial portfolio included lubricant eye drops, eyelid cleansers, and nutritional supplements. In 2011, the company was acquired by Akorn for approximately $26 million to bolster its consumer health division. The flagship TheraTears brand was subsequently sold to Prestige Consumer Healthcare in 2021 following Akorn's restructuring.
- Therapeutic areas
- Ophthalmology
- Modalities
- Small moleculeDevice
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Advanced Vision Research.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Advanced Vision Research.